Neuropathic Eye Pain clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Azithromycin for Meibomian Gland Disease
open to eligible people ages 18 years and up
This study aims to elucidate the effectiveness of oral azithromycin in treating symptomatic dry eye syndrome secondary to Meibomian gland dysfunction.
San Francisco, California
Our lead scientists for Neuropathic Eye Pain research studies include Thuy Doan, MD, PhD Julie Schallhorn, MD, MS.